Board Changes

RNS Number : 1373M

Verditek PLC

26 April 2018

 

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/2014 ("MAR"). Upon the publication of this announcement, this inside information is now considered to be in the public domain.

Verditek PLC

("Verditek" or the "Company")

Board Changes

Verditek plc, (AIM: VDTK), the clean technology company, is delighted to announce the appointment of The Rt Hon Lord Willetts as Non-Executive Chairman, with immediate effect.

Lord Willetts served as Minister for Universities and Science from 2010 to 2014 in the Coalition government. He was Member of Parliament for Havant between 1992 and 2015 and is now a member of the House of Lords.

Lord Willetts has a wealth of business experience, serving also on the Boards of Surrey Satellite Technology Limited and The Biotech Growth Trust. He is also a Board Member at the UK Research and Innovation (UKRI) and a Visiting Professor at King's College London. In addition, he is the Chairman of the Eight Great Technologies Fund which recently announced a funding intiative with a group of major Chinese technology investors.

Concurrently, José Luis del Valle, Non-Executive Director of Verditek plc has informed the Board that he is under consideration to be nominated as the Non-Executive Chairman of a Spanish banking institution subject to regulatory approval by the Bank of Spain (Banco de España). As such, due to regulatory and legal requirements, he will not be able to continue in his capacity as a Non-Executive Director of Verditek plc. However, José Luis has requested, and it has been agreed, that his resignation will be effective May 9^th 2018 to ensure the new Chairman, Lord David Willetts has all the necessary support on joining Verditek.

Lord Willetts commented: "I am excited to join Verditek as Chairman and, as a strong supporter of clean technologies, I look forward to guiding this forward-thinking business in its mission to commercialise green technologies. I believe that Verditek's innovative range of clean energy products will help to meet the growing demand for a greener, cleaner planet."

Dr. Geoff Nesbitt, former Chairman and Interim CEO of Verditek plc, said: "Lord Willetts has an outstanding track record in supporting the development of science and technology. His passion in these fields, combined with his extensive business experience and knowledge of the technology sector, will be hugely beneficial to Verditek. I would also like to take this opportunity to thank José Luis for his contribution to the Company and wish him well in his endeavours."

The information required by Schedule 2 paragraph (g) of the AIM Rules for Companies in respect of Lord Willetts is set out in the Appendix.

Enquiries:

Verditek plc

Geoffrey Nesbitt (Interim CEO)                                               [e-mail]

Whiteoaks Consultancy 

Mary Fitzgerald                                                                       [phone]

Bekki Bushnell                                                                        [phone]

[e-mail] 

Stockdale Securities Limited (NOMAD and Broker)

Antonio Bossi/David Coaten                                                   [phone]

www.stockdalesecurities.com 

Appendix

Regulatory disclosures (in accordance with Rule 17 and Schedule Two, paragraph (g), of the AIM Rules for Companies):

Lord David Lindsay Willetts, aged 62, is, or has been during the last five years, a director of the following companies:

Current directorships:

Genome Research Limited

Marchmount Executive Services Limited

Sirius Constellation Limited

Surrey Satellite Technology Limited

The Biotech Growth Trust Plc

Eight Great Technologies Fund

The Francis Crick Institute Limited

Vantix Diagnostics, Inc.

Previous directorships:

Borough of Havant Sport and Leisure Trust

Lord Willetts is also a member of the board of the following organizations:

Biotech Industry Association

British Science Association

Science Museum

The Francis Crick Institute

The Resolution Foundation

UK Research and Innovation (UKRI)

No further disclosures are required under Rule 17 and Schedule Two, paragraph (g), of the AIM Rules for Companies.

About Verditek

Verditek plc (AIM: VDTK), the clean technology company, is headquartered in London. Verditek is dedicated to commercialising proven technology that can deliver significant competitive advantage compared to conventional industrial solutions. From light-weight solar modules, cutting edge de-odourisation, and ground-breaking CO₂ capture, Verditek is realising tomorrow's technologies today.

For further information, please visit verditek.com

 

END

 

 

BOAEELFLVZFEBBF